Frontier Labs Commercialize Biology Foundation Models
Frontier labs keep moving biology foundation models from free academic releases to metered, API-only commercial access, which concentrates control of genomic and protein inference inside a few platform companies.
forming · confidence 40 · Emerging (watchlist) · tracking since November 12, 2026 · updated November 12, 2026
Why the conviction moved
- Nov 12Strengthened +4
DeepMind's AlphaGenome 2 finds 30% of causal variants on the TenK10K test, nearly double its predecessor. It was trained on more than 107 million single-cell profiles and launched as a private preview for commercial research rather than an open release. Gating access at launch keeps genomic inference inside Google's platform from the start.
Source trail
Supporting · November 12, 2026
AlphaGenome 2 finds 30% of causal variants on the TenK10K test, nearly double its predecessor
DeepMind's AlphaGenome 2 finds 30% of causal variants on the TenK10K test, nearly double its predecessor. It was trained on more than 107 million single-cell profiles and launched as a private preview for commercial research rather than an open release. Gating access at launch keeps genomic inference inside Google's platform from the start.
Google DeepMind
Unlock full source trail, score history, and daily updates.
Unlock TrendsTownsquare
Argue the thesis in Townsquare.